We establish subsidiaries by identifying excellent domestic and foreign partners

To develop novel, immune-related therapies, we co-founded IMMUNO DESIGNERS Co., Ltd. in November 2020 with Professor Bruce Beutler of UT Southwestern Medical Center, a world-renowned scholar and 2011 Nobel Prize in Physiology or Medicine winner. Using mouse models, Dr. Beutler discovered that TLR recognizes pathogens directly, and for this contribution, he won the Nobel Prize. This changed the perception that innate immunity was controlled not by simple inflammatory reactions but by an advanced signaling system. This contributed to the revelation of the mechanism of immune system activity and led to the development of effective treatments for immune-related disorders such as allergies and asthma.